JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, cilt.28, sa.2, ss.402-406, 2013 (SCI-Expanded)
In this study, we have synthesised (3,4-dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and a series of its derivatives (5, 13-16) and tested the ability of these compounds to inhibit two metalloenzyme human carbonic anhydrase (hCA, EC 4.2.1.1) isozymes, hCA I and hCA II. The synthesised compounds showed inhibitory effect on hCA I and hCA II isozymes. The results showed that synthesised compounds (5, 13-16) demonstrated the best inhibition activity against hCA I (IC50: 3.22-54.28 mu M) and hCA II (IC50: 18.52-142.01 mu M). The compound 14 showed the highest inhibiton effect against hCA I (IC50: 3.22 mu M; K-i: 1.19 +/- 1.4 mu M). On the other hand, the compound 13 showed the highest inhibiton effect against hCA II (IC50: 18.52 mu M; K-i: 3.25 +/- 1.13 mu M).